Visiopharm Granted a Worldwide Patent on Alignment of Virtual Slides

Visiopharm Granted a Worldwide Patent on Alignment of Virtual Slides
The ability to align and subsequently analyze digitized serial sections is gaining importance for a number of research and diagnostic applications related to tissue based biomarkers. Tumor Cell Detection: One popular application is tumor detection us...
Read more

Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational pathology

Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational pathology
• Breast cancer patients in Europe are set to benefit from more objective diagnosis • Philips’ digital pathology offering to be complemented with Visiopharm breast cancer panel algorithms Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,...
Read more

Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow

Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow
Today ISENET and Visiopharm announce a non-exclusive world-wide distribution agreement to provide Visiopharm image analysis with the Galileo TMA instrument, along with the Visiopharm Tissuearray™ imaging module, a part of ONCOTOPIX®, for tissue-ba...
Read more